Founded in 2005 by three senior scientists, COREALIS Pharma is a Canadian provider of formulation development and clinical supply manufacturing. The company offers a spectrum of R&D services focused exclusively on pharmaceutical oral solid dosage forms (i.e. tablets, capsules, and granules) and Current Good Manufacturing Practices (cGMP) services for phase I, II and to a lesser extent, early phase III studies. COREALIS has R&D laboratories, cGMP laboratories, and phase I, II, and early phase III clinical trial manufacturing packaging suits.